Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stephens

Showing results (1031-1040 of 1,072) with videos related to

Pageof 108
Sort By:
Annals of the American Thoracic Society|August 12, 2021
Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial ProtocolRachel Kohn, Anil Vachani, Dylan Small, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancerJ H Chung, D Pavlick, R Hartmaier, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Journal of the National Cancer Institute|January 26, 2018
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal CancerFilippo Pietrantonio, Federica Di Nicolantonio, Alexa B Schrock, et al.
Cancer Discovery|December 21, 2013
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJustin M Balko, Jennifer M Giltnane, Kai Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2014
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trialsGlenn R Cunningham, Alisa J Stephens-Shields, Raymond C Rosen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2016
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone LevelsGlenn R Cunningham, Alisa J Stephens-Shields, Raymond C Rosen, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Pageof 108

Showing results (1031-1040 of 1,072) with videos related to

Sort By:
Pageof 108
Annals of the American Thoracic Society|August 12, 2021
Comparing Smoking Cessation Interventions among Underserved Patients Referred for Lung Cancer Screening: A Pragmatic Trial ProtocolRachel Kohn, Anil Vachani, Dylan Small, et al.
Cancer Immunology Research|September 28, 2016
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeDouglas B Johnson, Garrett M Frampton, Matthew J Rioth, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 26, 2017
Hybrid capture-based genomic profiling of circulating tumor DNA from patients with estrogen receptor-positive metastatic breast cancerJ H Chung, D Pavlick, R Hartmaier, et al.
The Oncologist|September 16, 2017
Comprehensive Genomic Profiling of 282 Pediatric Low- and High-Grade Gliomas Reveals Genomic Drivers, Tumor Mutational Burden, and Hypermutation SignaturesAdrienne Johnson, Eric Severson, Laurie Gay, et al.
Journal of the National Cancer Institute|January 26, 2018
ALK, ROS1, and NTRK Rearrangements in Metastatic Colorectal CancerFilippo Pietrantonio, Federica Di Nicolantonio, Alexa B Schrock, et al.
Cancer Discovery|December 21, 2013
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJustin M Balko, Jennifer M Giltnane, Kai Wang, et al.
The Journal of Clinical Endocrinology and Metabolism|December 31, 2014
Association of sex hormones with sexual function, vitality, and physical function of symptomatic older men with low testosterone levels at baseline in the testosterone trialsGlenn R Cunningham, Alisa J Stephens-Shields, Raymond C Rosen, et al.
The Journal of Clinical Endocrinology and Metabolism|June 30, 2016
Testosterone Treatment and Sexual Function in Older Men With Low Testosterone LevelsGlenn R Cunningham, Alisa J Stephens-Shields, Raymond C Rosen, et al.
The Oncologist|August 28, 2016
Clinical Actionability of Comprehensive Genomic Profiling for Management of Rare or Refractory CancersKim M Hirshfield, Denis Tolkunov, Hua Zhong, et al.
Oncotarget|July 15, 2015
Detection of novel and potentially actionable anaplastic lymphoma kinase (ALK) rearrangement in colorectal adenocarcinoma by immunohistochemistry screeningJeeyun Lee, Hee Cheol Kim, Jung Yong Hong, et al.
Pageof 108